In patients showing cognitive decline, a new blood test for Alzheimer's is expected to make diagnosis more convenient, ...

Novartis' Fabhalta improved hemoglobin, reduced fatigue and eliminated transfusion need in a Phase 3B PNH study presented at the 2025 EHA Congress.

Scientists with the Fralin Biomedical Research Institute at VTC have created an engineered model of the supportive tissue ...

Using advanced single-nuclei RNA sequencing (snRNA-seq) and a widely used preclinical model for Alzheimer's disease, ...